The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Agree.
We want TRX to fully demonstrate high value growth on growth years and this will reflect in a better share price. Really think this will be 150 million + company in the next 5 years, million in 10 if they are not bought out beforehand.
I bought some more today while there is little attention and a gentle upward pressure.
I re-read the Interims from Sept 22 and Sept 23 and the FY results from March, and it convinced me to add to my holding :)
BOD statements in the HYs and FYs, as well as in the recent IMC presentation, are understated but very optimistic about achieving rapid growth without further dilution, or possibly even without touching the $10m credit facility.
This is where research and patience pays off. TRX is at the inflection point from loss-making to generating a profit. Once TRX can really spell out their growth in their HY and FY Reports (coming v soon), and market sentiment drags itself out of the gutter, this will fly.
Agree - inexplicable - good luck to you
I have bought a large chunk of TRX following strong management and products. Only a matter of time IMO
Bought another 10k
in a sensible market, the sp would be much higher (EV/rev>3) imv
tp £1++
A tiny increase I know, but it's in the right direction.
This share seems to do better with no news rather than good news!
Frustrating to be sure
Would imagine that if so stays as low as it is whilst business is clearly turning round with a bright future that we will be taken over
It's a bit of a catch 22 situation: new investors will want to see the share price rising before they buy in; the share price will rise when new buyers buy in. Institutional investors are holding pat.
When the much predicted profit arrives and the company starts generating cash, we will see movement.
Shame that yesterday's rns didn't tickle the SP a bit, but I guess that's to be expected.
I am however, starting to wonder what exactly it will take? I still believe there is a lot of potential still to be tapped into, but the good news we've been getting for quite some time doesn't seem to have much effect
160,000 shares is a pretty decent holding in my book :-)
After that RNS , I'm sure many of us here still hold more shares individually than Brian Phillips.
Very impressive senior management. The SP will look after itself when it needs to but I understand the frustration at the lack of more immediate positivity. A really well run company by individuals with experience and a track record which should also give confidence.
Yep, makes absolutely no sense. Anyone who sat in on yesterday's presentation would have seen the confidence, vision and excitement of the company's leaders. Trite to say but as they continue down their growth road taking share from competitors in a growth area of healthcare and as distributors and regulatory approvals come in, the SP of this company is only going in one direction. I may be wrong but that will happen quickly when it happens. Have not sold a share since buying my large stake
And the market cap has gone down from 70p despite the growth reported.
IMO the share price is what the company is valued at. IE , sp x shares in issues give you the market cap?
TRX's share price isn't low because the "MMs have no clue how to value AIM companies". It's low because of the wider circumstances: massive net outflows from UK stock market, no appetite for AIM or small caps, we're in a risk-off bear market where PIs are happy to take 5-10% in the short term rather than invest for the long term.
There won't be much change in the short-term with recession/stagflation/current Govt, but nothing to do with MMs, they just react to events.
I get that spindok, but a 10% rise when TR1 is reported? I guess this will be back at 49 within a week , so nothing gained by all the company success. In fact , we are down circa 20% from the last TR1 . That's my gripe , there is no reward until a takeover is announced because the MM's have no clue how to value AIM companies. When the takeover of any company is announced they soon enough put the price up accordingly because the suitor has done the valuation for them.
I mean plus 7% today? They drop it 7% on nothing.
Watching their live interview - what a class act they are
Wouldn't it be great if a top end sportsman/woman eulogised over Tissue Regenix after knee ligament reconstruction surgery. " It's the best knee I've ever had, over here son, on me 'ed, goals pay the rent".
Ah well, I will sit and wait.
It takes quite a while for the penny to drop. Many boom and busters have popped off. Real investors wait a day or two to study the scene.... Bit frustrating though that this is so s l o w ...
Stockmarket is a joke , especially AIM. I was under the impression the markets value companies on future prospects? This hasn't even made the 70p mark yet and it's in a much better shape than then. IMO the only time a company is valued is when there is a takeover , otherwise the mm's will give you nothing for success. Anyway , back in the drawer they go.
Under the radar.will a big pharma nip in and snap us up?
OIC: no linking to the competition. Google is your friend.
a 'research' note from finncap (https://*********************/ - free registration maybe required) contains this:
"we nudge up our forecasts to reflect the adjusted ebitda progress but suggest that the risk of changes remains to the upside. we reiterate our target price of 120p, at which level the stock would trade on 2023e ev/sales of 3.9x, dropping to 3.4x in fy 2024, which we believe reflects the above-market revenue growth (2-year cagr of 18%) and the move towards an operationally cash generative business in 2024, which is also supported by peer group (differentiated regenerative medical products) acquisitions on 4-8x ev/sales multiples. "
tp of 120p would be nice ;)
Been under the radar, and remains under the radar... one day that will change!